HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%
Reuters
Jul 25
HCA Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%
HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.